Yogi Adityanath Coronavirus CoVaxin Latest News Updates: Uttar Pradesh Coronavirus Vaccine Clinical Trial In Gorakhpur And Lucknow Approval From Yogi Adityanath Government | Kovaxin Phase III trial approved in UP; Human trials to be held in Lucknow and Gorakhpur, two nodal officers appointed


  • Hindi news
  • Local
  • Uttar pradesh
  • Yogi Adityanath Coronavirus CoVaxin Latest News Updates: Uttar Pradesh Coronavirus Vaccine Clinical Trial In Gorakhpur And Lucknow Approval From Yogi Adityanath Government

Lucknow23 minutes ago

  • Copy link

Nominated as Director of PGI, Lucknow and Principal of BRD Medical College, Gorakhpur. (Symbolic photo)

  • CM Yogi approves Phase III of Bharat Biotech Company Vaccine

In Lucknow and Gorakhpur in Uttar Pradesh, Bharat Biotech Company will trial its third stage Kovaxin. Bharat Biotech Company had sought permission from the Uttar Pradesh government for the third phase of the trial. CM Yogi has approved the letter of Additional Chief Secretary Amit Mohan Prasad. Additional Chief Secretary has nominated the Principal of Gorakhpur BRD Medical College and Director of SGPGI, Lucknow for the trial.

Additional Chief Secretary of Health Department Amit Mohan Prasad has confirmed this. He informed that RK Dhiman, Director, SGPGI, Lucknow and Ganesh Kumar, Principal of Gorakhpur BRD Medical College, have been appointed for the vaccine trial. All necessary approvals for this trial have to be taken by the company itself. All information related to the trial will have to be shared continuously with Additional Chief Secretary Medical Education Dr. Rajneesh Dubey.

Permission from person to be taken for clinical trial

The third stage trial of the Kovid vaccine made by Bharat Biotech will be done in a human trial. It will be necessary to obtain consent from the person on whom the clinical trial will be conducted. India Biotech company will now test its third testing vaccine in Lucknow and Gorakhpur on a large scale.

0

.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.